Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$69.18
-4.15-5.66%
At close: -
$69.32
0.140.20%
After Hours: 5:50 PM EDT
Comments
Loading...
Insmed Analyst Ratings and Price Targets | NASDAQ:INSM | Benzinga
Insmed Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Insmed Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
RBC Capital
UBS
Guggenheim
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Insmed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | — | B of A Securities | Jason Zemansky74% | $92 → $96 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | — | RBC Capital | Leonid Timashev37% | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2025 | Buy Now | — | UBS | Trung Huynh38% | $105 → $110 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | — | RBC Capital | Leonid Timashev37% | → $100 | Initiates | → Outperform | Get Alert |
| 02/25/2025 | Buy Now | — | Guggenheim | Vamil Divan75% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | — | Truist Securities | Nicole Germino41% | $105 → $108 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | — | Stifel | Stephen Willey50% | $97 → $96 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Wells Fargo | Tiago Fauth41% | $85 → $107 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | — | Stifel | Stephen Willey50% | $88 → $97 | Maintains | Buy | Get Alert |
| 02/07/2025 | Buy Now | — | JP Morgan | Jessica Fye66% | $83 → $92 | Maintains | Overweight | Get Alert |
| 02/07/2025 | Buy Now | — | Guggenheim | Vamil Divan75% | $95 → $101 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $85 → $90 | Maintains | Overweight | Get Alert |
| 11/22/2024 | Buy Now | — | JP Morgan | Jessica Fye66% | $74 → $83 | Maintains | Overweight | Get Alert |
| 11/01/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
| 11/01/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $85 → $100 | Maintains | Buy | Get Alert |
| 10/09/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $84 → $86 | Maintains | Buy | Get Alert |
| 10/03/2024 | Buy Now | — | JP Morgan | Jessica Fye66% | $72 → $74 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer52% | — | Reiterates | → Overweight | Get Alert |
| 08/29/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $88 → $85 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | — | TD Cowen | Ritu Baral35% | $75 → $98 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | — | UBS | Trung Huynh38% | $78 → $84 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | — | Stifel | Stephen Willey50% | $74 → $88 | Maintains | Buy | Get Alert |
| 07/12/2024 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $60 → $85 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | — | Goldman Sachs | Andrea Tan40% | $74 → $102 | Maintains | Buy | Get Alert |
| 07/09/2024 | Buy Now | — | Guggenheim | Vamil Divan75% | $70 → $95 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $70 → $90 | Maintains | Buy | Get Alert |
| 07/05/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $83 → $83 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 07/01/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $68 → $88 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | — | Evercore ISI Group | Josh Schimmer52% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | Buy Now | — | JP Morgan | Jessica Fye66% | $55 → $72 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | — | Mizuho | Graig Suvannavejh54% | $36 → $82 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | — | Stifel | Stephen Willey50% | $67 → $74 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | — | Stifel | Stephen Willey50% | $39 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | TD Cowen | Ritu Baral35% | $45 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | UBS | Trung Huynh38% | $46 → $58 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | Goldman Sachs | Andrea Tan40% | $49 → $74 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | Wells Fargo | Tiago Fauth41% | $55 → $77 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $48 → $68 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | Barclays | Leon Wang66% | $40 → $63 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | — | JP Morgan | Jessica Fye66% | $36 → $55 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $52 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $43 → $60 | Maintains | Overweight | Get Alert |
| 05/28/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/16/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | $48 → $48 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | — | Goldman Sachs | Andrea Tan40% | $40 → $49 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | — | Mizuho | Graig Suvannavejh54% | $35 → $36 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $40 → $43 | Maintains | Overweight | Get Alert |
| 04/23/2024 | Buy Now | — | Truist Securities | Nicole Germino41% | → $48 | Initiates | → Buy | Get Alert |
| 04/11/2024 | Buy Now | — | Barclays | Leon Wang66% | $37 → $40 | Maintains | Overweight | Get Alert |
| 04/01/2024 | Buy Now | — | Wells Fargo | Tiago Fauth41% | $55 → $55 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | — | Guggenheim | Vamil Divan75% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | — | UBS | Trung Huynh38% | → $46 | Initiates | → Buy | Get Alert |
| 02/23/2024 | Buy Now | — | B of A Securities | Jason Zemansky74% | $37 → $40 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | — | Wolfe Research | Andy Chen36% | → $42 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | — | JP Morgan | Jessica Fye66% | → $36 | Reinstates | → Overweight | Get Alert |
| 10/27/2023 | Buy Now | — | Mizuho | Graig Suvannavejh54% | $33 → $35 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | $46 → $54 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | → $46 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | Buy Now | — | Evercore ISI Group | Josh Schimmer52% | $32 → $42 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | — | Mizuho | Graig Suvannavejh54% | $30 → $33 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | — | B of A Securities | Jason Zemansky74% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | Buy Now | — | Guggenheim | Vamil Divan75% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | — | Stifel | Stephen Willey50% | $33 → $35 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2023 | Buy Now | — | Mizuho | Graig Suvannavejh54% | $28 → $30 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | — | Guggenheim | Vamil Divan75% | → $50 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | → $52 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | $49 → $46 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | — | Credit Suisse | Judah Frommer65% | → $46 | Reiterates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein42% | → $52 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | — | Barclays | Leon Wang66% | $37 → $35 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | — | Goldman Sachs | Andrea Tan40% | $44 → $39 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | — | Mizuho | Graig Suvannavejh54% | → $28 | Initiates | → Buy | Get Alert |
| 12/08/2022 | Buy Now | — | Barclays | Leon Wang66% | → $37 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | Buy Now | — | Barclays | Leon Wang66% | → $37 | Initiates | → Overweight | Get Alert |
| 11/18/2022 | Buy Now | — | B of A Securities | Jason Zemansky74% | → $39 | Initiates | → Buy | Get Alert |
| 10/27/2022 | Buy Now | — | SVB Leerink | Joseph Schwartz65% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim46% | $53 → $49 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | — | Cowen & Co. | Ritu Baral35% | $56 → $53 | Maintains | Outperform | Get Alert |
| 07/15/2022 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $46 → $41 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | — | Goldman Sachs | Andrea Tan40% | $56 → $48 | Maintains | Buy | Get Alert |
| 04/27/2022 | Buy Now | — | Goldman Sachs | Andrea Tan40% | → $56 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Insmed (INSM) stock?
The latest price target for Insmed (NASDAQ:INSM) was reported by B of A Securities on March 20, 2025. The analyst firm set a price target for $96.00 expecting INSM to rise to within 12 months (a possible 38.49% upside). 61 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insmed (INSM)?
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by B of A Securities, and Insmed maintained their buy rating.
When was the last upgrade for Insmed (INSM)?
There is no last upgrade for Insmed
When was the last downgrade for Insmed (INSM)?
There is no last downgrade for Insmed.
When is the next analyst rating going to be posted or updated for Insmed (INSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating Insmed (INSM) correct?
While ratings are subjective and will change, the latest Insmed (INSM) rating was a maintained with a price target of $92.00 to $96.00. The current price Insmed (INSM) is trading at is $69.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.